2019年1期
Cancer Drug Resistance
Review
- Alkylating anticancer agents and their relations to microRNAs
- Germline variants in cancer therapy
- Resistance to anti-tubulin agents: From vinca alkaloids to epothilones
- The use of pharmacogenetics to increase the safety of colorectal cancer patients treatedwith fluoropyrimidines
- Somatic pharmacogenomics of gastrointestinal stromal tumor
- Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
- Pharmacogenetics of anticancer monoclonal antibodies
- lnfluence of lysosomal sequestration on multidrug resistance in cancer cells
- Opportunities and challenges of implementing Pharmacogenomics in cancer drug development